AU2010335656B2 - Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue - Google Patents

Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue Download PDF

Info

Publication number
AU2010335656B2
AU2010335656B2 AU2010335656A AU2010335656A AU2010335656B2 AU 2010335656 B2 AU2010335656 B2 AU 2010335656B2 AU 2010335656 A AU2010335656 A AU 2010335656A AU 2010335656 A AU2010335656 A AU 2010335656A AU 2010335656 B2 AU2010335656 B2 AU 2010335656B2
Authority
AU
Australia
Prior art keywords
composition according
composition
solvent
calcipotriol
polyoxypropylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010335656A
Other languages
English (en)
Other versions
AU2010335656A1 (en
Inventor
Karsten Petersson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma AS filed Critical Leo Pharma AS
Publication of AU2010335656A1 publication Critical patent/AU2010335656A1/en
Application granted granted Critical
Publication of AU2010335656B2 publication Critical patent/AU2010335656B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2010335656A 2009-12-22 2010-12-22 Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue Ceased AU2010335656B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPCT/DK2009/000264 2009-12-22
DK2009000264 2009-12-22
US29310810P 2010-01-07 2010-01-07
US61/293,108 2010-01-07
PCT/DK2010/000184 WO2011076209A2 (en) 2009-12-22 2010-12-22 Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue

Publications (2)

Publication Number Publication Date
AU2010335656A1 AU2010335656A1 (en) 2012-07-19
AU2010335656B2 true AU2010335656B2 (en) 2015-05-07

Family

ID=43618136

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010335656A Ceased AU2010335656B2 (en) 2009-12-22 2010-12-22 Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue

Country Status (14)

Country Link
US (1) US20130023501A1 (cg-RX-API-DMAC7.html)
EP (1) EP2515866B1 (cg-RX-API-DMAC7.html)
JP (1) JP5732471B2 (cg-RX-API-DMAC7.html)
CN (1) CN102770121B (cg-RX-API-DMAC7.html)
AU (1) AU2010335656B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012015437A2 (cg-RX-API-DMAC7.html)
CA (1) CA2785254A1 (cg-RX-API-DMAC7.html)
ES (1) ES2452872T3 (cg-RX-API-DMAC7.html)
IL (1) IL220517A (cg-RX-API-DMAC7.html)
MX (1) MX2012007225A (cg-RX-API-DMAC7.html)
NZ (1) NZ601001A (cg-RX-API-DMAC7.html)
RU (1) RU2559084C2 (cg-RX-API-DMAC7.html)
WO (1) WO2011076209A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201204622B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2902282C (en) * 2013-02-27 2023-03-14 Laurie Robert BATT Transdermal formulations
KR102486797B1 (ko) * 2016-03-09 2023-01-11 삼성전자 주식회사 전자 장치 및 전자 장치의 디스플레이 구동 방법
CN107643354B (zh) * 2016-07-22 2022-02-01 重庆华邦胜凯制药有限公司 卡泊三醇起始原料a及相关杂质的分离与测定方法
CN106265511A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种性能优异的卡泊三醇倍他米松自微乳制剂
CN106265485A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种稳定性改善的卡泊三醇组合物
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
CA3157812C (en) * 2019-10-25 2024-10-22 Cardiol Therapeutics Inc. CANNABIDIOL COMPOSITIONS INTENDED FOR USE IN THE TREATMENT OF HEART CONDITIONS
KR102891680B1 (ko) 2020-07-28 2025-11-27 아큐티스 바이오테라퓨틱스, 인크. Jak 저해제 및 라우레스-4를 함유하는 국소 제형
WO2023114832A1 (en) 2021-12-15 2023-06-22 Arcutis Biotherapeutics, Inc. Stable formulations of shr0302

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000064450A1 (en) * 1999-04-23 2000-11-02 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Pharmaceutical composition
WO2006134272A1 (fr) * 2005-06-17 2006-12-21 Galderma Research & Development Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
WO2008065316A2 (fr) * 2006-11-30 2008-06-05 Galderma S.A. Compositions sous forme d'onguent comprenant un derive de vitamine d

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083974A (en) * 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
DE4011682A1 (de) * 1990-04-06 1991-10-10 Schering Ag 24-oxa-derivate in der vitamin d-reihe
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives
USRE39706E1 (en) 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
GB9611603D0 (en) * 1996-06-04 1996-08-07 Leo Pharm Prod Ltd Chemical compounds
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
AU2002363959B2 (en) * 2001-12-03 2007-12-13 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
DE602004027504D1 (de) 2003-07-24 2010-07-15 Leo Pharma As Aminobenzophenonverbindungen
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
CA2590479A1 (en) 2004-12-13 2006-06-22 Leo Pharma A/S Triazole substituted aminobenzophenone compounds
US8148537B2 (en) 2006-12-22 2012-04-03 Leo Pharma A/S Substituted acetophenones useful as PDE4 inhibitors
MY150075A (en) 2007-02-28 2013-11-29 Leo Pharma As Novel phosphodiesterase inhibitors
US7909624B2 (en) 2007-03-26 2011-03-22 Belkin International, Inc. Carabiner universal serial bus hub
EP2146703A1 (en) 2007-04-19 2010-01-27 Leo Pharma A/S Src family kinase inhibitors
WO2008134512A1 (en) * 2007-04-25 2008-11-06 Cytochroma Inc. Oral controlled release compositions comprising vitamin d compound and waxy carrier
EP2146780A1 (en) 2007-05-11 2010-01-27 Sonneborn Inc. Petrolatums having silicone-like properties
HRP20160488T1 (hr) 2008-12-19 2016-06-17 Leo Pharma A/S Triazolopiridini kao inhibitori fosfodiesteraze za liječenje kožnih bolesti

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000064450A1 (en) * 1999-04-23 2000-11-02 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Pharmaceutical composition
WO2006134272A1 (fr) * 2005-06-17 2006-12-21 Galderma Research & Development Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
WO2008065316A2 (fr) * 2006-11-30 2008-06-05 Galderma S.A. Compositions sous forme d'onguent comprenant un derive de vitamine d

Also Published As

Publication number Publication date
RU2012130411A (ru) 2014-01-27
CN102770121B (zh) 2014-10-15
EP2515866A2 (en) 2012-10-31
NZ601001A (en) 2014-07-25
HK1177696A1 (en) 2013-08-30
MX2012007225A (es) 2012-07-30
BR112012015437A2 (pt) 2016-03-15
JP2013515020A (ja) 2013-05-02
IL220517A0 (en) 2012-08-30
ES2452872T3 (es) 2014-04-03
WO2011076209A3 (en) 2012-02-23
US20130023501A1 (en) 2013-01-24
CA2785254A1 (en) 2011-06-30
CN102770121A (zh) 2012-11-07
AU2010335656A1 (en) 2012-07-19
IL220517A (en) 2016-08-31
RU2559084C2 (ru) 2015-08-10
EP2515866B1 (en) 2014-02-19
WO2011076209A2 (en) 2011-06-30
JP5732471B2 (ja) 2015-06-10
ZA201204622B (en) 2013-09-25

Similar Documents

Publication Publication Date Title
AU2010335656B2 (en) Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue
AU2010335654B2 (en) Cutaneous composition comprising vitamin D analogue and a mixture of solvent and surfactants
AU2009357263B2 (en) Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
AU2010335655B2 (en) Calcipotriol monohydrate nanocrystals
US9254296B2 (en) Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
HK1177696B (en) Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
HK1177695B (en) Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired